drugset / Trial / NCT00502320

Ramelteon in the Treatment of Sleep and Mood in Patients With Seasonal Affective Disorder

NCT00502320

RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this study is to determine whether treating sleep difficulties in patients with seasonal affective disorder also improves their depressive symptoms.

Timeline

Start
2006-09
Primary completion
2008-04
Completion
2008-07

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Ramelteon Unknown 8 mg